Last Posted: Oct 20, 2019
- Blending Insights from Implementation Science and the Social Sciences to Mitigate Inequities in Screening for Hereditary Cancer Syndromes
L Senier et al, MDPI, JPM, October 2019 - What Beyonce’s Dad And Angelina Jolie Have In Common
E Matloff, Forbes, October 18, 2019 - Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
J Tie et al, JAMA Oncology, October 17, 2019 - Cost-effectiveness of risk-stratified colorectal cancer screening based on polygenic risk – current status and future potential
SK Naber et al, JNCI SPectrum, October 17, 2019 - DNA Tests For Psychiatric Drugs Are Controversial But Some Insurers Are Covering Them
G Dangor, NPR, October 17, 2019 - Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical Trial.
Luen Stephen J et al. JAMA oncology 2018 4(10) 1335-1343 - Breast Cancer Surgical Risk Reduction for Patients With Inherited Mutations in Moderate Penetrance Genes.
Weiss Anna et al. JAMA surgery 2018 153(12) 1145-1146 - Current review of TP53 pathogenic germline variants in breast cancer patients outside Li-Fraumeni syndrome.
Fortuno Cristina et al. Human mutation 2018 39(12) 1764-1773 - Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas.
Chang P et al. AJNR. American journal of neuroradiology 2018 39(7) 1201-1207 - Engagement with Genetic Information and Uptake of Genetic Testing: the Role of Trust and Personal Cancer History.
Roberts Megan C et al. Journal of cancer education : the official journal of the American Association for Cancer Education 2018 33(4) 893-900
.png)
No hay comentarios:
Publicar un comentario